Cubist Systematic Strategies, LLC Icosavax, Inc. Transaction History

Cubist Systematic Strategies, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$5.62 - $11.51 $66,613 - $136,428	-11,853 Reduced 15.56%	64,308 $372,000
Q4 2022 Feb 14, 2023	BUY	$2.32 - $10.97 $119,271 - $563,967	51,410 Added 207.71%	76,161 $604,000
Q3 2022 Nov 14, 2022	BUY	$3.09 - $9.21 $76,480 - $227,956	24,751 New	24,751 $78,000
Q3 2022 Nov 14, 2022	BUY	$3.09 - $9.21 $76,480 - $227,956	24,751 New	24,751 $78,000
Q2 2022 Aug 15, 2022	SELL	$5.7 - $10.33 $285,758 - $517,873	-50,133 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.41 - $22.5 $221,086 - $1.13 Million	50,133 New	50,133 $353,000

1.37M

Ticker ICVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,885,200
Description
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.